PTC Therapeutics Inc (PTCT)
43.23
+0.34
(+0.79%)
USD |
NASDAQ |
Nov 22, 16:00
43.23
0.00 (0.00%)
After-Hours: 20:00
PTC Therapeutics Free Cash Flow: -274.19M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -274.19M |
| June 30, 2024 | -230.14M |
| March 31, 2024 | -199.47M |
| December 31, 2023 | -279.04M |
| September 30, 2023 | -343.25M |
| June 30, 2023 | -363.59M |
| March 31, 2023 | -403.42M |
| December 31, 2022 | -509.11M |
| September 30, 2022 | -409.03M |
| June 30, 2022 | -421.96M |
| March 31, 2022 | -395.50M |
| December 31, 2021 | -336.66M |
| September 30, 2021 | -327.02M |
| June 30, 2021 | -249.86M |
| March 31, 2021 | -271.06M |
| December 31, 2020 | -250.05M |
| September 30, 2020 | -193.10M |
| June 30, 2020 | -221.28M |
| March 31, 2020 | -197.82M |
| December 31, 2019 | -144.08M |
| September 30, 2019 | -142.07M |
| June 30, 2019 | -115.87M |
| March 31, 2019 | -72.09M |
| December 31, 2018 | -43.17M |
| Date | Value |
|---|---|
| September 30, 2018 | 0.355M |
| June 30, 2018 | -91.23M |
| March 31, 2018 | -77.56M |
| December 31, 2017 | -90.33M |
| September 30, 2017 | -124.13M |
| June 30, 2017 | -55.06M |
| March 31, 2017 | -92.62M |
| December 31, 2016 | -105.34M |
| September 30, 2016 | -122.08M |
| June 30, 2016 | -126.08M |
| March 31, 2016 | -131.60M |
| December 31, 2015 | -127.06M |
| September 30, 2015 | -107.27M |
| June 30, 2015 | -96.28M |
| March 31, 2015 | -85.62M |
| December 31, 2014 | -61.94M |
| September 30, 2014 | -65.27M |
| June 30, 2014 | -53.47M |
| March 31, 2014 | -53.52M |
| December 31, 2013 | -47.77M |
| September 30, 2013 | -43.98M |
| June 30, 2013 | -44.62M |
| March 31, 2013 | -39.25M |
| December 31, 2012 | -48.12M |
Free Cash Flow Range, Past 5 Years
-509.11M
Minimum
Dec 2022
-144.08M
Maximum
Dec 2019
-300.98M
Average
-276.61M
Median
Free Cash Flow Benchmarks
| ClearPoint Neuro Inc | -9.076M |
| Pfizer Inc | 8.227B |
| Vertex Pharmaceuticals Inc | -1.352B |
| BridgeBio Pharma Inc | -456.32M |
| Cassava Sciences Inc | -78.07M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -76.99M |
| Cash from Investing (Quarterly) | -42.68M |
| Cash from Financing (Quarterly) | -17.63M |
| Free Cash Flow Per Share (Quarterly) | -1.141 |
| Free Cash Flow to Equity (Quarterly) | -88.07M |
| Free Cash Flow to Firm (Quarterly) | -42.48M |
| Free Cash Flow Yield | -8.30% |